Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Obstructive Lung Diseases

  Free Subscription


2 Allergy
3 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
23 Arch Bronconeumol
3 Arerugi
1 Chest
2 Eur Respir J
8 J Asthma
1 J Investig Allergol Clin Immunol
1 Lancet
5 Respir Med
4 Respir Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. CAIT A, Wedel A, Arntz JL, Duinkerken J, et al
    Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis.
    Allergy. 2022 Jun 11. doi: 10.1111/all.15404.
    PubMed         Abstract available

  2. OWORA AH, Li R, Tepper RS, Ramsey CD, et al
    Impact of time-varying confounders on the association between early-life allergy sensitization and the risk of current asthma: a post-hoc analysis of a birth cohort.
    Allergy. 2022 Jun 10. doi: 10.1111/all.15403.

    Am J Respir Crit Care Med

    Managing Your Asthma: Avoiding Allergens.
    Am J Respir Crit Care Med. 2022;205:P25-P26.

  4. BOSE S, Madrigano J, Hansel NN
    When Health Disparities Hit Home: Redlining Practices, Air Pollution, and Asthma.
    Am J Respir Crit Care Med. 2022 Jun 13. doi: 10.1164/rccm.202206-1063.

  5. PETERS MC, Schiebler M, Cardet JC, Johansson MW, et al
    The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma.
    Am J Respir Crit Care Med. 2022 Jun 10. doi: 10.1164/rccm.202112-2745.
    PubMed         Abstract available

    Ann Allergy Asthma Immunol

  6. POLIVKA BJ, Huntington-Moskos L, Antimisiaris DE, Cavallazzi RS, et al
    Phenotyping Older Adults with Asthma via Cluster Analysis.
    Ann Allergy Asthma Immunol. 2022 Jun 10. pii: S1081-1206(22)00501.

  7. RURAN HB, Maciag MC, Murphy SE, Phipatanakul W, et al
    Cross-Sectional Study of Urinary Biomarkers of Environmental Tobacco and E-Cigarette Exposure and Asthma Morbidity.
    Ann Allergy Asthma Immunol. 2022 Jun 7. pii: S1081-1206(22)00499.

    Arch Bronconeumol

  8. DE-TORRES JP, Wisnivesky JP
    Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
    Arch Bronconeumol. 2021;57:679-680.

    Bronchiectasis and Eosinophils.
    Arch Bronconeumol. 2021;57:671-672.

  10. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
    Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
    Arch Bronconeumol. 2021;57:774-776.

  11. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
    Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
    Arch Bronconeumol. 2021;57:741-749.
    PubMed         Abstract available

  12. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021;57:731-732.

  13. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
    Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
    Arch Bronconeumol. 2021;57:464-470.
    PubMed         Abstract available

  14. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
    Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
    Arch Bronconeumol. 2021;57:614-615.

  15. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
    Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
    Arch Bronconeumol. 2021;57:593-594.

  16. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
    Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
    Arch Bronconeumol. 2021;57:577-583.
    PubMed         Abstract available

  17. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
    Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
    Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.

  18. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
    The 7 Cardinal Sins of COPD in Spain.
    Arch Bronconeumol. 2022;58:498-503.
    PubMed         Abstract available

  19. FERREIRO A, Granados G, Villar A
    Peribronchovascular emphysema. The Macklin effect.
    Arch Bronconeumol. 2021;57:697.

  20. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
    Plastic bronchitis and Noonan syndrome.
    Arch Bronconeumol. 2021;57:705.

  21. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
    Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
    Arch Bronconeumol. 2021;57:528-532.
    PubMed         Abstract available

  22. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
    Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Arch Bronconeumol. 2021;57:533-539.
    PubMed         Abstract available

  23. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
    Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
    Arch Bronconeumol. 2021;57:617-620.

  24. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021;57:621-622.

  25. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
    Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
    Arch Bronconeumol. 2021;57:630-636.
    PubMed         Abstract available

  26. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
    Arch Bronconeumol. 2021;57:662-664.

  27. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D supplementation: A treatment with possible benefits in asthma.
    Arch Bronconeumol. 2021;57:567-568.

  28. GARCIA-SANZ MT, Gonzalez-Barcala FJ
    COPD is more than just lung function: Let's not forget depression.
    Arch Bronconeumol. 2021;57:519-520.

  29. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    Arch Bronconeumol. 2022;58:482-489.
    PubMed         Abstract available

  30. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
    Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
    Arch Bronconeumol. 2022;58:474-481.
    PubMed         Abstract available


    Arerugi. 2022;71:293-296.

  32. FUKUMITSU K, Kanemitsu Y, Niimi A
    Arerugi. 2022;71:301-312.

  33. KUME H, Tomita H, Fukuhara A
    Arerugi. 2022;71:321-327.
    PubMed         Abstract available


  34. VAES AW, Spruit MA, Koolen EH, Antons JC, et al
    "Can Do, Do Do" Quadrants and 6-Year All-Cause Mortality in Patients With COPD.
    Chest. 2022;161:1494-1504.
    PubMed         Abstract available

    Eur Respir J

  35. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.

  36. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.

    J Asthma

  37. SEVERCAN EU, Bal CM, Gulen F, Tanac R, et al
    Identifying wheezing phenotypes in a pediatric Turkish cohort.
    J Asthma. 2022;59:1298-1304.
    PubMed         Abstract available

  38. VIJAYAN K, Karakattu SM, Bansal A, Thomas A, et al
    Immediate complications and flow volume changes during treatment phases of bronchial thermoplasty: a single-center descriptive study.
    J Asthma. 2022;59:1433-1437.
    PubMed         Abstract available

    Are we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?
    J Asthma. 2022;59:1360-1371.
    PubMed         Abstract available

  40. SUAREZ-LORENZO I, Hernandez-Brito E, Almeida-Quintana L, Llanos CG, et al
    Alpha-1 antitrypsin deficiency hidden in allegedly normal variants.
    J Asthma. 2022;59:1372-1375.
    PubMed         Abstract available

  41. EIJKEMANS M, Mommers M, Thijs C
    Comparison of parent reported physician diagnosed asthma and general practitioner registration.
    J Asthma. 2022 Jun 10:1-9. doi: 10.1080/02770903.2022.2087189.
    PubMed         Abstract available

  42. AKELMA Z, Cetin S, Baskaya N, Bostanci I, et al
    Preschool children with asthma during the Covid-19 pandemic: fewer infections, less wheezing.
    J Asthma. 2022 Jun 13:1-10. doi: 10.1080/02770903.2022.2089994.
    PubMed         Abstract available

  43. XIE L, Gelfand A, Mathew MS, Atem FD, et al
    Association of Corticosteroid Use and Attention Deficit/Hyperactivity Disorder in Asthmatic Children Varies by Age.
    J Asthma. 2022 Jun 13:1-13. doi: 10.1080/02770903.2022.2089995.
    PubMed         Abstract available

  44. SYAMLAL G, Dodd KE, Mazurek JM
    Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Asthma-COPD overlap among US working adults.
    J Asthma. 2022 Jun 13:1-14. doi: 10.1080/02770903.2022.2089997.
    PubMed         Abstract available

    J Investig Allergol Clin Immunol

  45. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force.
    J Investig Allergol Clin Immunol. 2022 Jun 8:0. doi: 10.18176/jiaci.0833.


  46. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    PubMed         Abstract available

    Respir Med

  47. SOUTO-MIRANDA S, Antao J, Rodrigues G, Mendes MA, et al
    Cut-off of the one-minute sit-to-stand test to detect functional impairment in people with chronic obstructive pulmonary disease.
    Respir Med. 2022;199:106892.
    PubMed         Abstract available

  48. DALIN DA, Lokke A, Kristiansen P, Jensen C, et al
    A systematic review of blood eosinophils and continued treatment with inhaled corticosteroids in patients with COPD.
    Respir Med. 2022;198:106880.
    PubMed         Abstract available

  49. YOHANNES AM, Murri MB, Hanania NA, Regan EA, et al
    Depressive and anxiety symptoms in patients with COPD: A network analysis.
    Respir Med. 2022;198:106865.
    PubMed         Abstract available

  50. AL CHIKHANIE Y, Bailly S, Amroussa I, Veale D, et al
    Clustering of COPD patients and their response to pulmonary rehabilitation.
    Respir Med. 2022;198:106861.
    PubMed         Abstract available

  51. ZAFARI Z, Lee TY, Sadatsafavi M
    External validation of lung function predictions in real-world cohorts of COPD.
    Respir Med. 2022;198:106859.
    PubMed         Abstract available

    Respir Res

  52. LIU P, Wang Y, Zhang N, Zhao X, et al
    Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease.
    Respir Res. 2022;23:154.
    PubMed         Abstract available

  53. LOPEZ-CAMPOS JL, Osaba L, Czischke K, Jardim JR, et al
    Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.
    Respir Res. 2022;23:152.
    PubMed         Abstract available

  54. SALO PM, Mendy A, Wilkerson J, Molsberry SA, et al
    Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis.
    Respir Res. 2022;23:150.
    PubMed         Abstract available

  55. SCHNEIDER S, Merfort I, Idzko M, Zech A, et al
    Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation.
    Respir Res. 2022;23:148.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.